Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportNeurosciences Track

Contribution of simultaneous PET-MRI to understanding the neuropharmacology of 5-HT1A receptor biased agonists.

Benjamin Vidal, Sylvain Fieux, Marjorie Villien, Didier Le Bars, Adrian Newman-Tancredi, Nicolas Costes and Luc Zimmer
Journal of Nuclear Medicine May 2017, 58 (supplement 1) 11;
Benjamin Vidal
2Lyon Neuroscience Research Center Lyon France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sylvain Fieux
2Lyon Neuroscience Research Center Lyon France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marjorie Villien
1CERMEP Lyon France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Didier Le Bars
1CERMEP Lyon France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adrian Newman-Tancredi
3Neurolixis Inc Dana Point CA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicolas Costes
1CERMEP Lyon France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Luc Zimmer
2Lyon Neuroscience Research Center Lyon France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 58 no. supplement 1 11

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online May 24, 2017.

Copyright & Usage 
© 2017

Author Information

  1. Benjamin Vidal2,
  2. Sylvain Fieux2,
  3. Marjorie Villien1,
  4. Didier Le Bars1,
  5. Adrian Newman-Tancredi3,
  6. Nicolas Costes1 and
  7. Luc Zimmer2
  1. 1CERMEP Lyon France
  2. 2Lyon Neuroscience Research Center Lyon France
  3. 3Neurolixis Inc Dana Point CA United States

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: May 2017 to April 2025

AbstractFullPdf
May 2017700
Jun 20177700
Jul 20172600
Aug 20171800
Sep 20171200
Oct 20173100
Nov 20171700
Dec 20171100
Jan 20181600
Feb 2018800
Mar 2018900
Apr 2018900
May 20182700
Jun 2018500
Jul 2018200
Aug 2018200
Sep 20184000
Oct 2018100
Nov 2018200
Dec 2018300
Feb 2019200
Mar 20192000
Apr 2019300
May 2019100
Jul 2019200
Sep 2019300
Nov 2019100
Dec 2019100
Jan 2020300
Feb 2020400
Mar 20201500
Apr 2020800
May 2020800
Jul 2020400
Aug 20201000
Sep 20202400
Oct 20201500
Nov 20201400
Dec 20201100
Jan 2021100
Feb 2021900
Mar 20212000
Apr 20212700
May 2021900
Jun 2021200
Jul 20211500
Aug 20213000
Sep 20211200
Oct 20211800
Nov 20215200
Dec 20213300
Jan 20226000
Feb 20221900
Mar 20221600
Apr 2022900
May 20222200
Jun 2022200
Aug 2022200
Sep 2022200
Oct 2022100
Nov 2022100
Dec 2022100
Jan 2023400
Feb 2023300
Mar 2023300
Apr 2023200
May 2023400
Jun 2023400
Jul 2023100
Aug 2023200
Sep 2023200
Oct 2023400
Nov 20231000
Dec 2023100
Jan 2024500
Feb 2024300
Mar 2024100
Apr 2024400
May 20241200
Jun 2024200
Jul 2024100
Aug 2024600
Sep 2024400
Oct 2024100
Nov 2024500
Dec 2024500
Jan 2025200
Feb 2025300
Mar 2025700
Apr 2025300
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 58, Issue supplement 1
May 1, 2017
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Contribution of simultaneous PET-MRI to understanding the neuropharmacology of 5-HT1A receptor biased agonists.
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Contribution of simultaneous PET-MRI to understanding the neuropharmacology of 5-HT1A receptor biased agonists.
Benjamin Vidal, Sylvain Fieux, Marjorie Villien, Didier Le Bars, Adrian Newman-Tancredi, Nicolas Costes, Luc Zimmer
Journal of Nuclear Medicine May 2017, 58 (supplement 1) 11;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Contribution of simultaneous PET-MRI to understanding the neuropharmacology of 5-HT1A receptor biased agonists.
Benjamin Vidal, Sylvain Fieux, Marjorie Villien, Didier Le Bars, Adrian Newman-Tancredi, Nicolas Costes, Luc Zimmer
Journal of Nuclear Medicine May 2017, 58 (supplement 1) 11;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Neurosciences Track

  • Impact of cognitive reserve in frontotemporal dementia illustrated by FDG-PET.
  • Quantification of brain cholinergic denervation in dementia with Lewy bodies using PET imaging with 18F-FEOBV
  • Kinetic evaluation of [18F]MOZAT PET imaging in humans.
Show more Neurosciences Track

Brain Imaging Council Young Investigator Award Symposium

  • Potential effect of a fluorine position in the aromatic molecule (CP-118,954) on the neuropharmacological property and PET imaging quantification for AChE expression
  • Optimization of S1P1-specific PET radioligands for imaging neuroinflammation
  • Evaluation of default mode network by quantitative 15O-labeled gases and water PET: comparison study between cerebral blood flow and oxygen consumption.
Show more Brain Imaging Council Young Investigator Award Symposium

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire